MetaCap

Phibro Animal Health Corporation Class A (PAHC)

NASDAQ: PAHCHealth CareBiotechnology: Pharmaceutical PreparationsUSD

37.02-0.70 (-1.86%)

Market open · Delayed 15 min · as of Oct 8, 9:38 AM ET

PAHC stock chart

Technical analysis

Key statistics

All statistics
Dividend yield
1.30% ($0.48)
Ex-dividend date
Sep 2, 2026
52-week range
28.25 – 60.08
Day range
37.02 – 37.53
Volume / Avg
2.88K / 235.16K
Beta
—
Next earnings
Nov 4, 2026

52-week range

$28.25$60.08

PAHC stock today

Shares of Phibro Animal Health (PAHC) are trading lower on Oct 8 at $37.02, a drop of 1.86% or $0.70 per share, versus the S&P 500's 0.34% decline. At this level, PAHC sits in the middle of its 52-week range of $28.25 to $60.08: 38.4% below the high, set on Apr 13, 2026 and 31.0% above the low. PAHC is up 1.0% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 0.3%.

Phibro Animal Health trades at 15.2x its trailing twelve-month earnings per share of $2.43. Its forward P/E of 9.6x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Phibro Animal Health's next earnings report is expected on Nov 4, 2026. Phibro Animal Health pays an annual dividend of $0.48 per share, a 1.30% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Phibro Animal Health

Company profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Daniel M. Bendheim J.D.
Headquarters
Teaneck, NJ
Employees
2,605
IPO year
2014
Website
pahc.com

Analyst forecast

Forecast

Consensus (4 analysts)

hold

Avg. price target

$44.00+18.85%

  • Strong buy 1
  • Buy 0
  • Hold 2
  • Sell 0
  • Strong sell 1

Target range

Low $35.00High $55.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Nov 4, 2026
EPS estimate
$0.77

Dividends

Dividend history
Annual dividend
$0.48
Last payment
$0.12
Ex-dividend date
Sep 2, 2026

PAHC news

All PAHC news

Phibro Animal Health peers

Health Care sector
PAHC peer companies
CompanyPrice% ChgMarket capCompare
ETONEton Pharmaceuticals Inc.53.79-1.99%$1.54Bvs PAHC
INVAInnoviva Inc.20.95-0.52%$1.51Bvs PAHC
SNDXSyndax Pharmaceuticals Inc.16.84-1.12%$1.50Bvs PAHC
STOKStoke Therapeutics Inc.24.23-0.25%$1.56Bvs PAHC
OCULOcular Therapeutix Inc.7.13-1.44%$1.56Bvs PAHC
QUREuniQure N.V.22.66-2.10%$1.57Bvs PAHC
CMPSCOMPASS Pathways Plc American Depository Shares11.63-0.51%$1.61Bvs PAHC
RAPPRapport Therapeutics Inc.30.20-2.14%$1.45Bvs PAHC

Indexes, lists and sector

Phibro Animal Health stock FAQ

What is Phibro Animal Health's stock price today?

PAHC last traded at $37.02 as of Oct 8, 9:38 AM EDT, down 1.86% on the day. Prices are delayed at least 15 minutes.

Does Phibro Animal Health pay a dividend?

Yes. Phibro Animal Health pays $0.48 per share annually, a 1.30% yield. The most recent dividend of $0.12 had an ex-dividend date of Sep 2, 2026.

When is Phibro Animal Health's next earnings date?

Phibro Animal Health is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $0.77.

What is PAHC's P/E ratio?

PAHC trades at a trailing P/E ratio of 15.23 and a forward P/E of 9.64.

Who is Phibro Animal Health's CEO?

Mr. Daniel M. Bendheim J.D. is the chief executive officer of Phibro Animal Health Corporation Class A, which has about 2,605 employees.

What is the PAHC 52-week high?

The 52-week high for PAHC is $60.08 and the 52-week low is $28.25. The stock is currently 38.4% below its high.

Compare PAHC